PharmaBoardroom

Ai Li Siow – Managing Director, Siemens Healthineers…

Siemens Healthineers Singapore’s Ai Li Siow outlines how her affiliate has pivoted in order to continue to support its customers in what was an…

Michael Altorfer – CEO, Swiss Biotech Association

Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses…

Ching Kiat LIM – Managing Director, Airhub Development,…

Changi Airport Group’s Ching Kiat LIM reflects on a challenging 2020 for the airline industry, Changi's longstanding excellence in pharmaceutical…

Antonella Santuccione Chadha – CEO pro-bono, Women’s…

Antonella Santuccione Chadha*, Head of Stakeholder Engagement for Alzheimer’s disease at Biogen and co-founder and CEO of the Women’s Brain…

Samir Khalil – Executive Director, PhRMA Middle East &…

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents many of the world’s leading innovative biopharmaceutical research…

Aligning Combination Product Regulations in Asia-Pacific: A…

Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia highlight some of the regulatory…

Importance of Reliance to Support Strengthening Latin American…

Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of FIFARMA Regulatory & Biologics…

Digital Health: India

An insight into digital health in Indian Pharma. Prepared in association with Nishith Desai & Associates, a leading law firm in India, this is an…

Medical Devices: India

An insight into medical devices in India. Prepared in association with Nishith Desai & Associates, a leading law firm in India, this is an extract…

Biosimilars and Biologics: Romania

The ins and outs of biosimilars and biologics in Romania. Prepared in association with Mușat & Asociații, a leading global law firm, this is…

Localization: Romania

The ins and outs of localization in Romanian pharma. Prepared in association with Mușat & Asociații, a leading global law firm, this is an…

Orphan Drugs and Rare Diseases: Romania

All legal aspects surrounding the orphan drugs and rare diseases in Romania. Prepared in association with Mușat & Asociații, a leading global…

Tagged with P